Seminar Schedule

2015 - 2016 Tuesday seminar schedule (view archive)
east pavilion auditorium
bjh south, 1st floor
12:00 - 1:00 PM


To be added to the seminar email list, send a request to


March 15

How Biomarkers for Alzheimer’s Disease Could Affect End-of-Life Choices
Rebecca Dresser, JD, School of Law, Washington University


March 22

Next Generation Biomarkers: Proteins, Algorithms, and Mechanisms
William Hu, MD, PhD, Assistant. Professor, Department of Neurology, Center for Neurodegenerative Diseases, Emory University School of Medicine\


March 29

The Knight ADRC Way: Us Versus Them
John C. Morris, MD, Friedman Distinguished Professor of Neurology and Director, Knight ADRC

April 5

Data Collection and Ensuring Reproducible Results
Chengjie Xiong, PhD; Professor of Biostatistics;  Elizabeth Grant, PhD, Research Statistician; Scot Fague, Senior Database Analyst; and Sade Agboola, Database Analyst, Knight ADRC Biostatistics Core, Washington University


April 12

A Predictive Prognostic Model for the Longitudinal Transition into Alzheimer’s Disease; A Test of Biomarker Contribution to Disease State
David K. Johnson, PhD, Associate Professor in Psychology and Gerontology, University of Kansas


April 19

No Seminar - 2016 AAN Meeting


April 26

Berislav V. Zlokovic, MD, PhD, Zilkha Chair in Alzheimer's Disease Research; Director, Zilkha Neurogenetic Institute, Professor and Chair, Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California


May 3

No Seminar - Hope Center Retreat


May 10

Tom J. Brett, PhD, Assistant Professor of Medicine, Division of Pulmonary and Critical Care, Washington University


May 17

Creutzfeldt-Jakob Disease
David Soleimani-Meigooni, MD, PGY-3 Neurology Resident, Washington University 


May 24

Treatment of Parkinson’s Disease Psychiatric Manifestations: Novel Approaches and Clinical Trial Design Considerations
Kevin Black, MD, Professor of Psychiatry, Washington University


May 31

Aging, Concussion and Will Smith: Update on the Neuropathology of Tauopathies
Nigel Cairns, PhD, Professor of Neurology, Washington University


June 7

Is Atherosclerosis the Alzheimer’s Disease of Blood Vessels? How the Cardiovascular and Neurodegenerative Fields Can Learn from One Another
Babak Razani, MD, PhD, Assistant Professor of Medicine and Pathology & Immunology, Center for Cardiovascular Research, Washington University


June 14

Combinatorial GWAS for Alzheimer's Disease
Sharlee Climer, PhD, Research Assistant Professor of Computer Science, Washington University


June 21

State of the Knight ADRC Lecture
John C. Morris, MD, Friedman Distinguished Professor of Neurology and Director, Knight ADRC, Washington University
Note New Location:  Connor Auditorium, Farrell Learning and Teaching Center


June 28

Purification and Quantitative Characterization of Amyloid-Beta Oligomers from AD Brain Lysates
Thomas Esparza, Senior Scientist, Washington University


If you have new findings to share in this series, please contact Jennifer Phillips at 286-2882 or to schedule a persentation date.

To be added to the seminar email list, send a request to


CME Documentation Information:


SPONSORED BY:  This activity is being sponsored by Washington University School of Medicine, Continuing Medical Education.


ACCREDITATION: Washington University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 


CREDIT:  Washington University designates this live educational activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.


DISCLOSURE POLICY:  It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  All faculty participating in this activity are expected to disclose to the audience any financial interest or other relationship he/she has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. All physicians’ disclosures were reported and are indicated with their presentations.  Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.


Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.


These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine, Continuing Medical Education is the sponsor for CME credits.